Revenue
$62.8B
Gross Margin
+70.7%
Operating Margin
+27.6%
Net Margin
+5.8%
Income statement waterfall for AbbVie (ABBV) — TTM through Q1 2026
Net income: $3.64B
Margin breakdown for AbbVie (ABBV) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $62.8B | $62.8B |
| Cost of Revenue | -$18.4B | $44.4B |
| Gross Profit | $44.4B | $44.4B |
| Operating Expenses | -$27.1B | $17.3B |
| Operating Income | $17.3B | $17.3B |
| Other Income / Expense | -$11.4B | $5.98B |
| Pre-tax Income | $5.98B | $5.98B |
| Income Tax | -$2.33B | $3.64B |
| Net Income | $3.64B | $3.64B |
- Revenue$62.8B
- Cost of Revenue-$18.4B
- Gross Profit$44.4B
- Operating Expenses-$27.1B
- Operating Income$17.3B
- Other Income / Expense-$11.4B
- Pre-tax Income$5.98B
- Income Tax-$2.33B
- Net Income$3.64B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
How this company returns cash to shareholders — buybacks, dividends, and stock splits.